These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6003268)

  • 41. [Changes in liver function and lipid-cholesterol metabolism in arteriosclerotics after ingestion of mineral water].
    Tkatschenko AF
    Z Physiother; 1973; 25(2):101-12. PubMed ID: 4721088
    [No Abstract]   [Full Text] [Related]  

  • 42. [Dynamics of some indices for the coagulation and anticoagulation systems of the blood in patients with coronary atherosclerosis under the effect of a diet containing marine products].
    Sycheva AN
    Vopr Pitan; 1967; 26(1):45-9. PubMed ID: 5611444
    [No Abstract]   [Full Text] [Related]  

  • 43. [Research on the metabolism of glycoproteins in aged atherosclerotic patients in relation to the evolutive stage and predominant localization of the disease].
    Enăchescu G; David C; Dumitrescu Z
    Fiziol Norm Patol; 1969; 15(2):181-7. PubMed ID: 5800157
    [No Abstract]   [Full Text] [Related]  

  • 44. [The concentration of different forms of vitamin A in the blood, liver and intima of the aorta under normal conditions and in atherosclerosis].
    Kalmykova VI
    Ter Arkh; 1971 Aug; 43(8):65-70. PubMed ID: 5151778
    [No Abstract]   [Full Text] [Related]  

  • 45. [Dynamic changes in mineral metabolism indexes in coronary atherosclerosis patients during diet therapy].
    Trangeĭzer VA
    Vopr Pitan; 1967; 26(3):53-5. PubMed ID: 5611458
    [No Abstract]   [Full Text] [Related]  

  • 46. [Lipid metabolism and oxidation-reduction properties of blood in patients with arteriosclerotic myocardiosclerosis during treatment with lipoic acid].
    Mikunis RI; Serkova VK; Shirkova TA
    Vrach Delo; 1976 Mar; (3):39-42. PubMed ID: 775779
    [No Abstract]   [Full Text] [Related]  

  • 47. [Blood glucose curve in patients with intractable coronary failure].
    Slidziewski K; Kraszewska Z; Lada W
    Pol Tyg Lek; 1975 Sep; 30(36):1479-81. PubMed ID: 1161608
    [No Abstract]   [Full Text] [Related]  

  • 48. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    Am Heart J; 2004 Jun; 147(6):1117-24. PubMed ID: 15199365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of diet therapy and increased physical activity on risk factors for atherosclerosis in obese patients with ischemic coronary heart disease].
    Omácka A; Dudková R; Baumgartner M
    Sb Lek; 2000; 101(1):121-5. PubMed ID: 10953644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes in blood capillary permeability in patients with coronary arteriosclerosis under the influence of an anti-arteriosclerosis diet].
    Chunakova EP; Prostiakov KM; Kondrat'eva AP
    Sov Med; 1967 Aug; 30(8):30-5. PubMed ID: 5610593
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative value of some indicators of lipid metabolism in arteriosclerosis].
    Voĭnikova SA
    Lab Delo; 1965; 9():515-6. PubMed ID: 4162253
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of aging on lipid metabolism and atherosclerosis (author's transl)].
    Kuzuya F
    Nihon Ronen Igakkai Zasshi; 1980 May; 17(3):223-9. PubMed ID: 7411998
    [No Abstract]   [Full Text] [Related]  

  • 53. [Palatal lipidophilia and prelipidophilia in coronary disease].
    Markiewicz M; Dubejko J; Michałowski R; Kutarski A
    Pol Tyg Lek; 1980 Jul; 35(27):1021-4. PubMed ID: 7422593
    [No Abstract]   [Full Text] [Related]  

  • 54. [The oxidative hypothesis of atherosclerosis and the use of antioxidants in coronary disease].
    Batlouni M
    Arq Bras Cardiol; 1997 Jan; 68(1):55-63. PubMed ID: 9334462
    [No Abstract]   [Full Text] [Related]  

  • 55. [Cellular and molecular mechanisms of arteriosclerosis].
    Chazov EI
    Ter Arkh; 1982; 54(11):3-8. PubMed ID: 7157168
    [No Abstract]   [Full Text] [Related]  

  • 56. [The therapeutic effect of a diet including sea foods in patients with coronary atherosclerosis].
    Paramonova EG; Korobkina GS; Sycheva AN; Chunakova EP; Shaternikov VA; Nemenova IuM; Loranskaia TI; Gvozdova AG; Kalinina NN; Tumarkina TI; Savchuk LA
    Sov Med; 1966 Feb; 29(2):11-5. PubMed ID: 5992597
    [No Abstract]   [Full Text] [Related]  

  • 57. [Involution of atherosclerosis in man].
    Zhdanov VS; Vikhert AM; Sarankin GE
    Kardiologiia; 1973 Feb; 13(2):39-44. PubMed ID: 4775782
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of xylite on clinico-biochemical indices in patients with coronary arteriosclerosis].
    Chunakova EP
    Vrach Delo; 1971 Nov; 11():33-7. PubMed ID: 5143271
    [No Abstract]   [Full Text] [Related]  

  • 59. [Change in potassium metabolism in the body during cardiac glycoside treatment].
    Bogoliubov VM; Lyskova MN; Kruglova ZG; Kaplan MA
    Ter Arkh; 1972 Jun; 44(6):20-3. PubMed ID: 4668457
    [No Abstract]   [Full Text] [Related]  

  • 60. [Certain indicators of liver function and histamine metabolism in patients with coronary atherosclerosis].
    Shustval' NF
    Vrach Delo; 1974 Feb; (2):63-7. PubMed ID: 4143229
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.